68700 Federal Register / Vol. 79, No. 222 / Tuesday, November 18, 2014 / Notices 

time for initiation pursuant to sections 

702(c)(1)(B) or 732(c)(1)(B) of the Act 

(19 U.S.C. 1671a(c)(1)(B) or 

1673a(c)(1)(B)), the Commission must 

reach a preliminary determination in 

antidumping and countervailing duty 

investigations in 45 days, or in this case 

by Monday, December 29, 2014. The 

Commission’s views must be 

transmitted to Commerce within five 

business days thereafter, or by Tuesday, 

January 6, 2015. 

For further information concerning 

the conduct of these investigations and 

rules of general application, consult the 

Commission’s Rules of Practice and 

Procedure, part 201, subparts A through 

E (19 CFR part 201), and part 207, 

subparts A and B (19 CFR part 207). 

DATES: Effective Date: Wednesday, 

November 12, 2014. 

FOR FURTHER INFORMATION CONTACT: 

Amy Sherman (202–205–3289), Office 

of Investigations, U.S. International 

Trade Commission, 500 E Street SW., 

Washington, DC 20436. Hearingimpaired persons can obtain 

information on this matter by contacting 

the Commission’s TDD terminal on 202– 

205–1810. Persons with mobility 

impairments who will need special 

assistance in gaining access to the 

Commission should contact the Office 

of the Secretary at 202–205–2000. 

General information concerning the 

Commission may also be obtained by 

accessing its internet server (http://

www.usitc.gov). The public record for 

this investigation may be viewed on the 

Commission’s electronic docket (EDIS) 

at http://edis.usitc.gov. 

SUPPLEMENTARY INFORMATION: 

Background.—These investigations 

are being instituted in response to a 

petition filed on Wednesday, November 

12, 2014, by Cornerstone Chemical 

Company, Waggaman, Louisiana. 

Participation in the investigation and 

public service list.—Persons (other than 

petitioners) wishing to participate in the 

investigations as parties must file an 

entry of appearance with the Secretary 

to the Commission, as provided in 

sections 201.11 and 207.10 of the 

Commission’s rules, not later than seven 

days after publication of this notice in 

the Federal Register. Industrial users 

and (if the merchandise under 

investigation is sold at the retail level) 

representative consumer organizations 

have the right to appear as parties in 

Commission antidumping duty and 

countervailing duty investigations. The 

Secretary will prepare a public service 

list containing the names and addresses 

of all persons, or their representatives, 

who are parties to these investigations 

upon the expiration of the period for 

filing entries of appearance. 

Limited disclosure of business 

proprietary information (BPI) under an 

administrative protective order (APO) 

and BPI service list.—Pursuant to 

section 207.7(a) of the Commission’s 

rules, the Secretary will make BPI 

gathered in these investigations 

available to authorized applicants 

representing interested parties (as 

defined in 19 U.S.C. § 1677(9)) who are 

parties to the investigations under the 

APO issued in the investigations, 

provided that the application is made 

not later than seven days after the 

publication of this notice in the Federal 

Register. A separate service list will be 

maintained by the Secretary for those 

parties authorized to receive BPI under 

the APO. 

Conference.—The Commission’s 

Director of Investigations has scheduled 

a conference in connection with these 

investigations for 9:30 a.m. on 

Wednesday, December 3, 2014, at the 

U.S. International Trade Commission 

Building, 500 E Street SW., Washington, 

DC. Requests to appear at the conference 

should be emailed to William.bishop@

usitc.gov and Sharon.bellamy@usitc.gov 

(DO NOT FILE ON EDIS) on or before 

Monday, December 1, 2014. Parties in 

support of the imposition of 

countervailing and antidumping duties 

in these investigations and parties in 

opposition to the imposition of such 

duties will each be collectively 

allocated one hour within which to 

make an oral presentation at the 

conference. A nonparty who has 

testimony that may aid the 

Commission’s deliberations may request 

permission to present a short statement 

at the conference. 

Written submissions.—As provided in 

sections 201.8 and 207.15 of the 

Commission’s rules, any person may 

submit to the Commission on or before 

Monday, December 8, 2014, a written 

brief containing information and 

arguments pertinent to the subject 

matter of the investigations. Parties may 

file written testimony in connection 

with their presentation at the conference 

no later than three days before the 

conference. If briefs or written 

testimony contain BPI, they must 

conform with the requirements of 

sections 201.6, 207.3, and 207.7 of the 

Commission’s rules. Please consult the 

Commission’s rules, as amended, 76 

Fed. Reg. 61937 (Oct. 6, 2011) and the 

Commission’s Handbook on Filing 

Procedures, 76 Fed. Reg. 62092 (Oct. 6, 

2011), available on the Commission’s 

Web site at http://edis.usitc.gov. 

In accordance with sections 201.16(c) 

and 207.3 of the rules, each document 

filed by a party to the investigations 

must be served on all other parties to 

the investigations (as identified by 

either the public or BPI service list), and 

a certificate of service must be timely 

filed. The Secretary will not accept a 

document for filing without a certificate 

of service. 

Authority: These investigations are being 

conducted under authority of title VII of the 

Tariff Act of 1930; this notice is published 

pursuant to section 207.12 of the 

Commission’s rules. 

By order of the Commission. 

Issued: November 12, 2014. 

Lisa R. Barton, 

Secretary to the Commission. 

[FR Doc. 2014–27227 Filed 11–17–14; 8:45 am] 

BILLING CODE 7020–02–P 

DEPARTMENT OF JUSTICE 

[OMB Number 1125–0003] 

Agency Information Collection 

Activities; Proposed eCollection; 

eComments Requested; Fee Waiver 

Request 

AGENCY: Executive Office for 

Immigration Review, Department of 

Justice 

ACTION: 30-Day notice. 

SUMMARY: The Department of Justice 

(DOJ), Executive Office for Immigration 

Review (EOIR), will be submitting the 

following information collection request 

to the Office of Management and Budget 

(OMB) for review and approval in 

accordance with the Paperwork 

Reduction Act of 1995. The proposed 

information collection was previously 

published in the Federal Register 

Volume 79, Number 178, page 55015, on 

September 15, 2014, allowing for a 60 

day comment period. 

DATES: Comments are encouraged and 

will be accepted for an additional 30 

days until December 18, 2014. 

FOR FURTHER INFORMATION CONTACT: If 

you have comments especially on the 

estimated public burden or associated 

response time, suggestions, or need a 

copy of the proposed information 

collection instrument with instructions 

or additional information, please 

contact Jeff Rosenblum, General 

Counsel, USDOJ–EOIR–OGC, Suite 

2600, 5107 Leesburg Pike, Falls Church, 

Virginia 20530; telephone: (703) 305– 

0470, or the DOJ Desk Officer at 202– 

395–5806. Written comments and/or 

suggestions can also be directed to the 

Office of Management and Budget, 

Office of Information and Regulatory 

Affairs, Attention Department of Justice 


tkelley on DSK3SPTVN1PROD with NOTICES
Federal Register / Vol. 79, No. 222 / Tuesday, November 18, 2014 / Notices 68701 

Desk Officer, Washington, DC 20530 or 

sent to OIRA_submissions@

omb.eop.gov. 

SUPPLEMENTARY INFORMATION: Written 

comments and suggestions from the 

public and affected agencies concerning 

the proposed collection of information 

are encouraged. Your comments should 

address one or more of the following 

four points: 

—Evaluate whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information will have 

practical utility; 

—Evaluate the accuracy of the agency’s 

estimate of the burden of the 

proposed collection of information, 

including the validity of the 

methodology and assumptions used; 

—Enhance the quality, utility, and 

clarity of the information to be 

collected; and 

—Minimize the burden of the collection 

of information on those who are to 

respond, including through the use of 

appropriate automated, electronic, 

mechanical, or other technological 

collection techniques or other forms 

of information technology, e.g., 

permitting electronic submission of 

responses. 

Overview of This Information 

Collection 

(1) Type of Information Collection: 

Extension of a currently approved 

collection. 

(2) Title of the Form/Collection: Fee 

Waiver Request. 

(3) Agency form number: EOIR–26A 

(OMB #1125–0003). 

(4) Affected public who will be asked 

or required to respond, as well as a brief 

abstract: Primary: An individual 

submitting an appeal or motion to the 

Board of Immigration Appeals. Other: 

Attorneys or representatives 

representing an alien in immigration 

proceedings before EOIR. Abstract: The 

information on the fee waiver request 

form is used by the Board of 

Immigration Appeals to determine 

whether the requisite fee for a motion or 

appeal will be waived due to an 

individual’s financial situation. 

(5) An estimate of the total number of 

respondents and the amount of time 

estimated for an average respondent to 

respond: It is estimated that 8,614 

respondents will complete each form 

within approximately 1 hour. 

(6) An estimate of the total public 

burden (in hours) associated with the 

collection: There are an estimated 8,614 

total annual burden hours associated 

with this collection. 

If additional information is required 

contact: Jerri Murray, Department 

Clearance Officer, United States 

Department of Justice, Justice 

Management Division, Policy and 

Planning Staff, Two Constitution 

Square, 145 N Street NE., Room 

3E.405B, Washington, DC 20530. 

Dated: November 13, 2014. 

Jerri Murray, 

Department Clearance Officer for PRA, U.S. 

Department of Justice. 

[FR Doc. 2014–27250 Filed 11–17–14; 8:45 am] 

BILLING CODE 4410–30–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Richard D. Vitalis, D.O.; Decision and 

Order 

On August 12, 2013, the Deputy 

Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration, issued an Order to 

Show Cause to Richard D. Vitalis, D.O. 

(Applicant), of Debary, Florida. GX 1. 

The Show Cause Order proposed the 

denial of Applicant’s application for a 

DEA Certificate of Registration on the 

ground that his continued ‘‘registration 

would be inconsistent with the public 

interest.’’ Id. at 2 (citing 21 U.S.C. 

823(f)). 

The Show Cause Order made 

numerous allegations against Applicant. 

First, it stated that on October 1, 2008, 

the Florida Department of Health (DOH) 

entered an emergency suspension of 

Applicant’s medical license on the basis 

of his history of alcohol dependency 

and his failure to comply with DOH 

orders requiring the monitoring of his 

medical practice. Id. The Order then 

specifically alleged that after 

reinstatement of his Florida medical 

license on March 26, 2009, Applicant 

materially falsified three applications 

for a DEA registration when he falsely 

answered ‘‘no’’ on each application to 

the liability question which asks: ‘‘Has 

the applicant ever surrendered (for 

cause) or had a state professional license 

or controlled substances registration 

revoked, suspended, denied, restricted 

or place on probation?’’ Id. at 2–3 (citing 

21 U.S.C. 843(a)(4)(A)). The Order 

alleged that Applicant submitted these 

applications on October 5, 2009; May 

22, 2012; and January 7, 2013. Id. 

The Show Cause Order also alleged 

that on October 6, 2009, Applicant 

became registered as a practitioner to 

handle schedule II controlled 

substances under DEA registration 

number FV1682269, at the registered 

address of 230 Caddie Court, Debary, 

Florida. The Order then alleged that 

between July 2010 and June 3, 2011, 

Applicant ‘‘issued and/or authorized 

prescriptions for controlled substances 

in Schedules 2N, 3, 3N, 4 and 5, for 

which [he] did not have the authority to 

handle, in violation of 21 U.S.C. 

822(b).’’ Id. at 3. The Show Cause Order 

also alleged that on June 3, 2011, 

Applicant’s registration was modified to 

add all schedules. Id. 

Next, the Show Cause Order alleged 

that between July 7, 2011 and March 22, 

2012, three law enforcement officers 

made six undercover visits to Applicant 

at All Family Medical (hereinafter, 

AFM), a state-registered pain 

management clinic. Id. The Order then 

alleged that at the conclusion of each 

visit, Applicant prescribed Schedule II 

and IV controlled substances, including 

oxycodone and Xanax, to the 

undercover officers, for other than a 

legitimate medical purpose and outside 

the usual course of professional practice 

in violation of applicable federal, state 

and local law. Id. at 3–4 (citing 21 CFR 

1306.04(a)). 

The Show Cause Order further alleged 

that a medical expert reviewed the 

undercover visits and determined that 

Applicant prescribed unnecessary and 

excessive doses of controlled substances 

to the undercover officers, in deviation 

from the standard of care in pain 

medicine. Id. at 4–5. The Order alleged 

that the Expert further found that 

Applicant failed to comply with 

Florida’s standards for the use of 

controlled substances for the treatment 

of pain, and that the prescriptions were 

issued for other than a legitimate 

medical purpose and outside the usual 

scope of professional practice. Id. at 5 

(citing Fla. Stat. § 456.44; Fla. Admin. 

Code r.64B15–14.005; 21 CFR 

1306.04(a)). 

Finally, the Show Cause Order alleged 

that on January 1, 2012, D.V., a 34-year 

old male died as a result of an 

accidental overdose of controlled 

substances. Id. The Order then alleged 

that on December 27, 2011, Applicant 

issued prescriptions to D.V. for 180 

tablets of oxycodone 30mg, 120 tablets 

of oxycodone 15mg, 40 tablets Percocet 

10/325 mg, 60 tablets of alprazolam 

2mg, and 90 tablets of Motrin 800mg, 

and that the prescriptions ‘‘were for 

other than a legitimate medical purpose 

and outside the usual scope of 

professional practice.’’ Id. (citing 21 

CFR 1306.04(a)). 

The Show Cause Order, which also 

notified Applicant of his right to request 

a hearing on the allegations or to submit 

a written statement in lieu of a hearing, 

the procedure for electing either option, 

and the consequence of failing to elect 


tkelley on DSK3SPTVN1PROD with NOTICES